Bio-Thera Solutions Ltd.

Industry

  • Pharmaceuticals
    • Generic Drugs
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies

Other Names/Subsidiaries

  • Biotech Biopharmaceutical Co., Ltd.
See more in Biomedtracker

Latest on Bio-Thera Solutions Ltd.

Generics Bulletin

Organon Looks To Tap Tocilizumab Potential Following Biogen Acquisition

 
• By Dean Rudge

Organon believes there is “considerable growth potential” for the Tofidence (tocilizumab-bavi) biosimilar to Genentech’s Actemra, after acquiring rights in the US for the product from Biogen, in a dea

Generics Bulletin

Dr Reddy’s Bags Rights To Two More Biosimilars In Deal With Bio-Thera

 
• By Dave Wallace

Dr Reddy’s has gained rights to a pair of proposed Stelara (ustekinumab) and Simponi (golimumab) biosimilars in multiple markets in south-east Asia, after striking an exclusive commercialization agree

Generics Bulletin

Bio-Thera And Stada Nudge Closer To Limited Golimumab Biosimilar Pool

 
• By Dean Rudge

Bio-Thera Solutions has matched Alvotech with the European Medicines Agency accepting for review the Chinese manufacturer’s proposed biosimilar to Johnson & Johnson’s Simponi (golimumab) once-mont

Generics Bulletin

Intas’ Accord Pens $165m Deal To Bring In Bio-Thera’s Golimumab In The US

 
• By Dean Rudge

Intas Pharmaceuticals’ Accord Biopharma unit has bolstered its US biosimilar pipeline after striking a deal to become the exclusive commercial partner for Bio-Thera Solutions’ BAT2506 proposed biosimi